Trenton Tollefson, MD
Neurology · Rochester, NYNPI 1770872707
Payments from drug & device makers
Across 30 payments — averaging $2758.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aquestive Therapeutics, Inc.$63K
- AbbVie$9K
- Immedica Pharma US, Inc.$9K
- Medtronic$1K
What the payments were for
- Travel & lodging$1,02476%
- Food & beverage$32524%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aquestive Therapeutics, Inc. | 13 | $62,768 |
| AbbVie | 6 | $9,471 |
| Immedica Pharma US, Inc. | 3 | $9,165 |
| Medtronic | 8 | $1,349 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIVA$1,147
How this compares
$82,753 in reported general payments places this provider in the 85th percentile of 1,623 neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpidiolexCannabidiol (Cbd) | 33 | $166,816 |
| LamictalLamotrigine | 42 | $68,476 |
| BriviactBrivaracetam | 37 | $63,678 |
| XcopriCenobamate | 32 | $46,713 |
| FycompaPerampanel | 37 | $45,185 |
| VimpatLacosamide | 43 | $42,748 |
| NayzilamMidazolam | 26 | $37,603 |
| AptiomEslicarbazepine Acetate | 18 | $32,311 |
| Lamictal XrLamotrigine | 18 | $30,841 |
| Clobazam | 166 | $25,333 |
| Oxtellar XrOxcarbazepine | 18 | $18,618 |
| Lamotrigine ErLamotrigine | 60 | $16,539 |
| Lamictal OdtLamotrigine | 12 | $13,215 |
| Carbamazepine ErCarbamazepine | 70 | $11,972 |
| Lacosamide | 159 | $10,858 |
Paid to pharmacies, not to this prescriber.
Other neurology in Rochester
- Kathleen MungerRochester$1.1M
- Christian GrommesNew York$9.9M
- Ilya KisterNew York$9.5M
- E DorseyNew York$8.5M
- Lauren SchaffNew York$8.2M
- Richard HolubAlbany$6.3M
- Martin SadowskiNew York$5.4M
- Lawrence HonigNew York$4.9M
- Laszlo MechtlerAmherst$4.3M
- Bennett MyersAmherst$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.